Search - tctmd.com

Displaying 121 - 140 of 541

Sort: Relevancy | Date

News Daily News

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

Michael O'Riordan

July 25, 2023

News Daily News

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Michael O'Riordan

July 07, 2023

News Daily News

LDL Control Remains Poor in CAD Patients: NHANES

Michael O'Riordan

July 05, 2023

News Daily News

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

Michael O'Riordan

June 23, 2023

News Daily News

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Michael O'Riordan

June 14, 2023

News Conference News EAS 2023

Variable Response to Novel PCSK9 Inhibitor Lerodalcibep in LIBERATE-HoFH

Michael O'Riordan

May 24, 2023

News Conference News EAS 2023

High LDL, Poor Treatment, Early Death: HoFH Registry Paints Grim Picture

Michael O'Riordan

May 23, 2023

News Conference News SCAI 2023

Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis

L.A. McKeown

May 22, 2023

News Daily News

Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA

Michael O'Riordan

May 03, 2023

News Daily News

Low-Dose Polypills Top Other Approaches for Initial BP Control: Meta-analysis

Todd Neale

April 26, 2023

News Daily News

Ezetimibe Plus Moderate-Dose Statins May Aid Compliance in the Elderly

Yael L. Maxwell

April 03, 2023

News Daily News

Borderline Cost-effectiveness for SGLT2 Inhibitors in HFpEF

Todd Neale

March 15, 2023

News Opinion CV Team Dispatch

March 2023 News Roundup

L.A. McKeown

March 15, 2023

News Conference News ACC 2023

Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes

Michael O'Riordan

March 04, 2023

News Daily News

Longer-Term ASCVD Risk Assessment Best for Younger Patients

Michael O'Riordan

February 16, 2023

News Daily News

Only Half of Revascularized PAD Patients Receive GDMT

L.A. McKeown

February 14, 2023

News Daily News

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

L.A. McKeown

January 24, 2023

News Daily News

UK’s NICE Recommends Lower-Risk Thresholds for Statin Therapy

Michael O'Riordan

January 20, 2023

News Daily News

PCSK9 Inhibition Shows Promise for Severe COVID-19 in Pilot Trial

Todd Neale

January 18, 2023

News Daily News

Zero CAC? LDL Cholesterol May Not Predict MI, ASCVD

Yael L. Maxwell

January 17, 2023

Advertisement

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

LDL Control Remains Poor in CAD Patients: NHANES

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Variable Response to Novel PCSK9 Inhibitor Lerodalcibep in LIBERATE-HoFH

High LDL, Poor Treatment, Early Death: HoFH Registry Paints Grim Picture

Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis

Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA

Low-Dose Polypills Top Other Approaches for Initial BP Control: Meta-analysis

Ezetimibe Plus Moderate-Dose Statins May Aid Compliance in the Elderly

Borderline Cost-effectiveness for SGLT2 Inhibitors in HFpEF

March 2023 News Roundup

Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes

Longer-Term ASCVD Risk Assessment Best for Younger Patients

Only Half of Revascularized PAD Patients Receive GDMT

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

UK’s NICE Recommends Lower-Risk Thresholds for Statin Therapy

PCSK9 Inhibition Shows Promise for Severe COVID-19 in Pilot Trial

Zero CAC? LDL Cholesterol May Not Predict MI, ASCVD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content